Improved risk stratification in prevention by use of a panel of selected 
circulating microRNAs

Keller, Till; Boeckel, Jes-Niels; Gross, Stefan; Klotsche, Jens; Palapies, Lars; Leistner, David; Pieper, Lars; Stalla, Günter K.; Lehnert, Hendrik; Silber, Sigmund; Pittrow, David; Maerz, Winfried; Doerr, Marcus; Wittchen, Hans-Ulrich; Baumeister, Sebastian E.; Voelker, Uwe; Felix, Stephan B.; Dimmeler, Stefanie; Zeiher, Andreas M.

doi:10.1038/s41598-017-04040-w

アイテム詳細

登録内容を編集ファイル形式で保存

一時保存へ追加

タグ情報を表示リリース履歴を表示詳細要約

公開

学術論文

Improved risk stratification in prevention by use of a panel of selected circulating microRNAs

MPS-Authors

/persons/resource/persons80539

Stalla, Günter K.
RG Clinical Neuroendocrinology, Clinical Research, Max Planck Institute of Psychiatry, Max Planck Society;

External Resource

There are no locators available

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

フルテキスト (公開)

s41598-017-04040-w.pdf
(出版社版), 2MB

付随資料 (公開)

There is no public supplementary material available

引用

Keller, T., Boeckel, J.-N., Gross, S., Klotsche, J., Palapies, L., Leistner, D., Pieper, L., Stalla, G. K., Lehnert, H., Silber, S., Pittrow, D., Maerz, W., Doerr, M., Wittchen, H.-U., Baumeister, S. E., Voelker, U., Felix, S. B., Dimmeler, S., & Zeiher, A. M. (2017). Improved risk stratification in prevention by use of a panel of selected circulating microRNAs. SCIENTIFIC REPORTS, 7:. doi:10.1038/s41598-017-04040-w.

引用: https://hdl.handle.net/21.11116/0000-0001-94DF-D

要旨

Risk stratification is crucial in prevention. Circulating microRNAs have been proposed as biomarkers in cardiovascular disease. Here a miR panel consisting of miRs related to different cardiovascular pathophysiologies, was evaluated to predict outcome in the context of prevention. MiR-34a, miR-223, miR-378, miR-499 and miR-133 were determined from peripheral blood by qPCR and combined to a risk panel. As derivation cohort, 178 individuals of the DETECT study, and as validation cohort, 129 individuals of the SHIP study were used in a case-control approach. Overall mortality and cardiovascular events were outcome measures. The Framingham Risk Score(FRS) and the SCORE system were applied as risk classification systems. The identified miR panel was significantly associated with mortality given by a hazard ratio(HR) of 3.0 (95% (CI): 1.09-8.43; p = 0.034) and of 2.9 (95% CI: 1.32-6.33; p = 0.008) after adjusting for the FRS in the derivation cohort. In a validation cohort the miR-panel had a HR of 1.31 (95% CI: 1.03-1.66; p = 0.03) and of 1.29 (95% CI: 1.02-1.64; p = 0.03) in a FRS/SCORE adjusted-model. A FRS/SCORE risk model was significantly improved to predict mortality by the miR panel with continuous net reclassification index of 0.42/0.49 (p = 0.014/0.005). The present miR panel of 5 circulating miRs is able to improve risk stratification in prevention with respect to mortality beyond the FRS or SCORE.